DMBi001-A-1

General#

Cell Line

hPSCreg Name DMBi001-A-1
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 21st April 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Department of Medical Biotechnology (DMB)

External Databases

BioSamples SAMEA8770928
CLO CLO_0103299

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research: allowed
Clinical: not allowed
Commercial: not allowed
Subclone of

Donor Information#

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

External Databases (Donor)

BioSamples SAMEA8770927

Ethics#

Also have a look at the ethics information for the parental line DMBi001-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation#

General

The source cell information can be found in the parental cell line DMBi001-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions#

Medium Essential 8™

Characterisation#

No characterisation data could be found for this subclone. Please open parental cell line DMBi001-A

Genotyping#

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification#

Disease/phenotype related modifications
laminin alpha 2-related dystrophy
Synonyms
  • LAMA2-related muscular dystrophy
Genetic modifications
LAMA2 (target)
Gene knock-out
6q22.33
CRISPR-associated (CRISPR/Cas) System